BAXTER AHB8611 ELECTROLYTE SOLUTION COMPOUND SODIUM LACTATE (HARTMANN'S SOLUTION) 5000ML Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

baxter ahb8611 electrolyte solution compound sodium lactate (hartmann's solution) 5000ml

baxter healthcare pty ltd - calcium chloride; potassium chloride; sodium lactate; sodium chloride - parenteral liquid/solution/suspension - calcium chloride mineral-calcium-salt active 0.27 g/l; potassium chloride mineral-potassium active 0.4 g/l; sodium lactate mineral-sodium active 3.22 g/l; sodium chloride mineral-sodium-salt active 6.0 g/l - nutrition & metabolism - all animals - dehydration | electrolyte replacement

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 1000mL bag Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 1000ml bag

baxter healthcare pty ltd - glucose, quantity: 45 g (equivalent: glucose monohydrate, qty 50 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 500mL bag Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 500ml bag

baxter healthcare pty ltd - glucose, quantity: 22.5 g (equivalent: glucose monohydrate, qty 25 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 250mL bag Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 250ml bag

baxter healthcare pty ltd - glucose, quantity: 11.25 g (equivalent: glucose monohydrate, qty 12.5 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER SEVOFLURANE sevoflurane 250mL inhalation liquid bottle Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter sevoflurane sevoflurane 250ml inhalation liquid bottle

baxter healthcare pty ltd - sevoflurane, quantity: 250 ml - inhalation - excipient ingredients: - for induction and maintenance of general anaesthesia in adults and paediatric patients undergoing surgery.

Baxter Irrigation Sets Singapur - engleski - HSA (Health Sciences Authority)

baxter irrigation sets

baxter healthcare (asia) pte ltd - general hospital - baxter irrigation sets are indicated for the delivery of irrigating solutions from the fluid container to the irrigation site during bladder irrigation or endoscopic procedures including cytoscopy, transurethral resection and arthroscopic procedures. the sets are intended for use with baxter irrigating solutions in plastic containers such as uromatic(r) or arthromatic (r) plastic containers.

Baxter Homechoice Claria APD Cycler Singapur - engleski - HSA (Health Sciences Authority)

baxter homechoice claria apd cycler

baxter healthcare (asia) pte ltd - gastroenterology & urology - baxter's homechoice claria apd cycler is intended for automatic control of dialysis solution exchanges in the treatment of pediatric and adult renal failure patients undergoing peritoneal dialysis.

Ketamine-Baxter Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

ketamine-baxter

baxter healthcare ltd - ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml - solution for injection - 100 mg/ml - active: ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml excipient: nitrogen water for injection - ketamine-baxter is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine-baxter is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/10 mL solution for injection vial Australija - engleski - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/10 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/20 mL solution for injection vial Australija - engleski - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/20 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).